Discovery and Characterization of an Endogenous CXCR4 Antagonist-Reference-Cited by-同舟云学术

Discovery and Characterization of an Endogenous CXCR4 Antagonist

Published:2015-05 Issue:5 Volume:11 Page:737-747
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zirafi Onofrio,Kim Kyeong-Ae,Ständker Ludger,Mohr Katharina B.,Sauter Daniel,Heigele Anke,Kluge Silvia F.,Wiercinska Eliza,Chudziak Doreen,Richter Rudolf,Moepps Barbara,Gierschik Peter,Vas Virag,Geiger Hartmut,Lamla Markus,Weil Tanja,Burster Timo,Zgraja Andreas,Daubeuf Francois,Frossard Nelly,Hachet-Haas Muriel,Heunisch Fabian,Reichetzeder Christoph,Galzi Jean-Luc,Pérez-Castells Javier,Canales-Mayordomo Angeles,Jiménez-Barbero Jesus,Giménez-Gallego Guillermo,Schneider Marion,Shorter James,Telenti Amalio,Hocher Berthold,Forssmann Wolf-Georg,Bonig Halvard,Kirchhoff Frank,Münch Jan

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. The lysosome: from waste bag to potential therapeutic target;Appelqvist;J. Mol. Cell Biol.,2013

2. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery;Aristoteli;J. Proteome Res.,2007

3. Cathepsin D—many functions of one aspartic protease;Benes;Crit. Rev. Oncol. Hematol.,2008

4. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry;Bleul;Nature,1996

5. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines;Bonig;Blood,2006

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability;Journal of Controlled Release;2024-09

2. A deep attention model for wide-genome protein-peptide binding affinity prediction at a sequence level;International Journal of Biological Macromolecules;2024-09

3. An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-07-30

4. CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans;Science Signaling;2024-03-19

5. Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines;Advanced Science;2024-03-11